MAPT and Alzheimer disease: Although the mechanisms by which ApoE4 exerts its effects on AD pathologies have been more clearly defined for Aβ (i.e., ApoE genotype affects Aβ clearance rate by slowing clearance), our results add to the growing body of recent findings, suggesting the involvement of ApoE4 on tau accumulation as well.